Pricey Hepatitis Drug a Good Bet in U.S. Prisons, Study Says

October 21, 2014 12:54 AM

13 0

MONDAY, Oct. 20, 2014 (HealthDay News) -- Using an expensive drug to treat prison inmates with hepatitis C is more cost-effective than another treatment option, according to a new study.

More than 500,000 prison inmates in the United States have hepatitis C, which causes liver damage. It's spread by contact with infected blood.

Read more

To category page

Loading...